Current practice and attitudes of australian obstetricians toward population-based carrier screening for inherited conditions

Twin Research and Human Genetics

Volumn 16, Issue 2, 2013, Pages 601-607

  Stark, Zornitza ^a,b   Massie, John ^b,c   Mcclaren, Belinda ^b   Ioannou, Liane ^b   Cousens, Nicole ^b   Lewis, Sharon ^b   Metcalfe, Sylvia ^b,c   Delatycki, Martin B ^b,c,d  

^a Genetic Health Services Victoria   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d AUSTIN HEALTH   (Australia)

Author keywords

carrier screening; cystic fibrosis; screening programs; thalassaemia

Indexed keywords

ARTICLE; AUSTRALIA; BETA THALASSEMIA; CLINICAL PRACTICE; CYSTIC FIBROSIS; E-MAIL; FEMALE; FRAGILE X SYNDROME; GYNECOLOGIST; HUMAN; MALE; MASS SCREENING; OBSTETRICS; PHYSICIAN ATTITUDE; PREPREGNANCY CARE; PRIORITY JOURNAL; QUESTIONNAIRE; SPINAL MUSCULAR ATROPHY;

ATTITUDE; COHORT STUDIES; DISEASES IN TWINS; FEMALE; GENETIC DISEASES, INBORN; GENETIC TESTING; HETEROZYGOTE DETECTION; HUMANS; MALE; MASS SCREENING; NEW ZEALAND; OBSTETRICS; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; QUESTIONNAIRES; TWINS;

EID: 84875999464     PISSN: 18324274     EISSN: None     Source Type: Journal    
DOI: 10.1017/thg.2012.152     Document Type: Article

References (33)

1. AmericanCollege ofObstetricians andGynecologists (ACOG) and the American College of Medical Genetics (ACMG). (2001). Preconception and prenatal carrier screening for cystic fibrosis.Washington, DC: Author
2. Berkenstadt,M.,Ries-Levavi, L.,Cuckle,H.,Peleg,L.,&Barkai, G. (2007). Preconceptional and prenatal screening for fragile X syndrome: Experience with 40,000 tests. [Evaluation studies]. Prenatal Diagnosis, 27, 991-994
3. Cao, A., Pintus, L., Lecca, U., Olla, G., Cossu, P., Rosatelli, C., & Galanello, R. (1984). Control of homozygous betathalassemia by carrier screening and antenatal diagnosis in Sardinians. Clinical Genetics, 26, 12-22
4. Cao, A., Saba, L., Galanello, R., & Rosatelli, M. C. (1997). Molecular diagnosis and carrier screening for beta thalassemia. Journal of the American Medical Association, 278, 1273-1277
5. Castellani, C.,Picci, L., Tamanini,A., Girardi, P.,Rizzotti, P.,& Assael, B.M. (2009). Association between carrier screening and incidence of cystic fibrosis. JAMA, 302, 2573-2579
6. Cousens,N. E., Gaff, C. L., Metcalfe, S. A., & Delatycki,M. B. (2010). Carrier screening for beta-thalassaemia: A review of international practice. European Journal ofHumanGenetics, 18, 1077-1083
7. Delatycki, M. B. (2008). Population screening for reproductive risk for single gene disorders in Australia: Now and the future. Twin Research and Human Genetics, 11, 422-430
8. Delatycki, M., Allen, K., & Williamson, R. (2002). Insurance agreement to facilitate genetic testing. Lancet, 359, 1433
9. Hale, J. E., Parad, R. B., & Comeau, A. M. (2008). Newborn screening showing decreasing incidence of cystic fibrosis. New England Journal of Medicine, 358, 973-974
10. Harris, H., Scotcher, D., Hartley, N., Wallace, A., Craufurd, D., & Harris, R. (1996). Pilot study of the acceptability of cystic fibrosis carrier testing during routine antenatal consultations in general practice. British Journal of General Practice, 46, 225-227
11. Hausen, J. (2012, February 26). Gardiner couple sues medical providers in wrongful birth case. Bozeman Daily Chronicle
12. HumanGenetics Society of Australasia (HGSA). (2009). Cystic fibrosis population screening position paper. Retrieved from http://www.hgsa.com.au/ images/UserFiles/Attachments/ CysticFibrosisPositionPaper.pdf
13. Ioannou, L., Massie, J., Lewis, S., Petrou, V., Gason, A., Metcalfe, S., . . . Delatycki, M. B. (2010). Evaluation of a multi-disease carrier screening programme in Ashkenazi Jewish high schools. Clinical Genetics, 78, 21-31
14. Kaback,M.M., Nathan, T., & Greenwald, S. (1997). Tay-Sachs disease: Heterozygote screening and prenatal diagnosis. US experience and world perspective. In M. M. Kaback (Ed.), Tay-Sachs disease, screening and prevention (pp. 13-36). New York: Alan R Liss
15. Levenson, D. (2010). New test could make carrier screening more accessible. American Journal of Medical Genetics Part A, 152A(4), vii-viii
16. Locock, L., & Kai, J. (2008). Parents' experiences of universal screening for haemoglobin disorders: Implications for practice in a new genetics era. British Journal of General Practice, 58, 161-168
17. Massie, J., Petrou, V., Forbes, R., Curnow, L., Ioannou, L., Dusart, D., . . .Delatycki, M. (2009). Population-based carrier screening for cystic fibrosis in Victoria: The first three years experience. Australian and New Zealand Journal of Obstetrics and Gynaecology, 49, 484-489
18. McClaren, B. J., Metcalfe, S. A., Aitken, M., Massie, R. J., Ukoumunne, O. C., & Amor, D. J. (2010). Uptake of carrier testing in families after cystic fibrosis diagnosis through newborn screening. European Journal of Human Genetics, 18, 1084-1089
19. McClaren, B. J., Metcalfe, S. A., Amor, D. J., Aitken, M., & Massie, J. (2011). A case for cystic fibrosis carrier testing in the general population. Medical Journal of Australia, 194, 208-209
20. Mennie, M. E., Gilfillan, A., Compton, M., Curtis, L., Liston, W. A., Pullen, I., . . . Brock, D. J. (1992). Prenatal screening for cystic fibrosis. Lancet, 340, 214-216
21. Metcalfe, S., Jacques, A., Archibald, A., Burgess, T., Collins, V., Henry, A., . . . Cohen, J. (2008). A model for offering carrier screening for fragile X syndrome to nonpregnant women: Results froma pilot study.Genetics inMedicine, 10, 525-535
22. Modell, B., & Mouzouras, M. (1982). Social consequences of introducing antenatal diagnosis for thalassemia. Birth Defects Original Article Series, 18, 285-291
23. Modra, L. J., Massie, R. J., & Delatycki, M. B. (2010). Ethical considerations in choosing a model for population-based cystic fibrosis carrier screening.Medical Journal ofAustralia, 193, 157-160
24. Morgan, M. A., Driscoll, D. A., Mennuti, M. T., & Schulkin, J. (2004). Practice patterns of obstetrician-gynecologists regarding preconception and prenatal screening for cystic fibrosis. Genetics in Medicine, 6, 450-455
25. Morgan, M. A., Driscoll, D. A., Zinberg, S., Schulkin, J., & Mennuti, M. T. (2005). Impact of self-reported familiarity with guidelines for cystic fibrosis carrier screening. Obstetrics & Gynecology, 105, 1355-1361
26. RANZCOG. (2009). College statement: Pre-pregnancy counselling and routine antenatal assessment in the absence of pregnancy complications. Retrieved from http://www. ranzcog.edu.au/publications/statements/C-obs3.pdf
27. RANZCOG. (2010). Prenatal screening for fetal abnormalities. A statement from the The Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Retrieved from http://www.ranzcog.edu.au/publications/ collegestatements.shtml
28. Scriver,C.R., Bardanis,M., Cartier, L.,Clow, C. L., Lancaster, G. A., & Ostrowsky, J. T. (1984). Beta-thalassemia disease prevention: Genetic medicine applied. American Journal of Human Genetics, 36, 1024-1038
29. Su, Y.N.,Hung,C.C.,Lin,S.Y.,Chen,F.Y.,Chern, J. P.,Tsai,C., . . . Lee, C. N. (2011). Carrier screening for spinalmuscular atrophy (SMA) in 107,611 pregnant women during the period 2005-2009: A prospective population-based cohort study. PloS One, 6, e17067
30. Sugarman, E. A., Nagan, N., Zhu, H., Akmaev, V. R., Zhou, Z., Rohlfs, E. M., . . . Allitto, B. A. (2012). Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: Clinical laboratory analysis of >72,400 specimens. European Journal of Human Genetics, 20, 27- 32
31. Wald,N. J., George, L.M.,Wald,N.M.,&Mackenzie, I. (1993). Couple screening for cystic fibrosis. Lancet, 342, 1307-1308
32. Wilkins-Haug, L., Hill, L., Schmidt, L., Holzman, G. B., & Schulkin, J. (1999). Genetics in obstetricians' offices: A survey study. Obstetrics & Gynecology, 93, 642-647
33. Zeesman, S., Clow, C. L., Cartier, L., & Scriver, C. R. (1984). A private view of heterozygosity: Eight-year follow-up study on carriers of the Tay-Sachs gene detected by high school screening inMontreal.American Journal ofHumanGenetics, 18, 769-778